Skip to content
DefDex

Federal award

PANTHERA BIOPHARMA, LLC

HDTRA113C0007

Contract

Obligated and Ceiling

Obligated (net)
$11,090,280.35
Ceiling (potential value, not spending)
$11,184,175.61
Current value
$11,184,175.61
Gross positive obligations
$11,184,175.61

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
PANTHERA BIOPHARMA, LLC · UFSEPG4LASN7
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
PANTHERA BIOPHARMA, LLC · UFSEPG4LASN7
Awarding agency
Department of War · sub-agency 9763 · office S0530A
Funding agency
Department of War · sub-agency 9761
Product or service (PSC)
AD92 · R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Industry (NAICS)
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PIID
HDTRA113C0007
Award type code
D
Actions
13 · Feb 22, 2013 to Aug 14, 2020
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History13

Award actions
DateFYModAction typeObligationCompany in company totals
Aug 14, 2020FY2020A00002M−$93,895.26
—
Jul 10, 2017FY2017P00010C$895,215.57
—
Apr 26, 2017FY2017P00009B$0.00
—
Mar 22, 2017FY2017P00008G$900,000.00
—
Oct 26, 2016FY2017P00007B$2,499,852.00
—
Aug 23, 2016FY2016P00006B$0.00
—
Oct 19, 2015FY2016P00005B$2,098,717.00
—
May 19, 2015FY2015P00004G$1,398,965.11
—
Jan 12, 2015FY2015P00003B$1,077,371.00
—
Mar 20, 2014FY2014P00002G$1,177,207.34
—
Feb 12, 2014FY2014P00001D$0.00
—
Jan 31, 2014FY2014A00001M$0.00
—
Feb 22, 2013FY20130—$1,136,847.59
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.